ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0060

ANCA-associated Vasculitis in Caucasian and Hispanics of the Inland Empire of Southern California

Sandy Lee1, Patil Injean1, Paulina Tran2, Deepa Panikkath1 and Christina Downey1, 1Loma Linda University Medical Center, Redlands, CA, 2UC Riverside School of Medicine, Riverside, CA

Meeting: ACR Convergence 2020

Keywords: ANCA associated vasculitis, Granulomatosis with Polyangiitis (GPA), Minority Health, population studies, race/ethnicity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, November 6, 2020

Title: Healthcare Disparities in Rheumatology Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: ANCA-associated vasculitis (AAV) is often studied in the Caucasian population with few studies looking at the disease in other races. Disease presentation and treatment implications of autoimmune conditions vary by ethnicity, as seen in systemic lupus erythematous. A 2014 study of the Chicago area compared AAV in Hispanic and Caucasian patients and found increased disease severity, as defined by the Birmingham Vasculitis Activity Score (BVAS) and the Vasculitis Disease Index (VDI), with greater renal involvement in Hispanics. We performed a similar study examining the differences in AAV in the Hispanic and Caucasian populations living in the Inland Empire region of Southern California.

Methods: A retrospective study was conducted on data extracted from the Loma Linda University Medical Center and the Riverside University Health System’s Electronic Medical Record, using ICD 9 and ICD 10 CM codes pertaining to vasculitis. Data span the dates of January 1, 2003 to December 31, 2019. Vasculitis cases were classified using the Diagnostic and Classification of the Systemic Vasculitis (DCVAS). Data extracted from the electronic charts include demographics, ICU admission due to vasculitis flare, presence of chronic kidney disease or end stage renal disease (ESRD), BVAS on presentation and VDI as detailed on recent clinic visit. We calculated odds ratios for the categorical data and ran Independent sample T-test for the continuous data with alpha equal to 0.05 for statistical significance. 

Results: 129 charts were included in the analysis with 66 Hispanics and 63 Caucasians (see table 1). 72 cases of Granulomatosis Polyangiitis (GPA), 47 cases of Microscopic Polyangiitis (MPA) and 10 cases of Eosinophilic Granulomatosis Polyangiitis (EGPA) were identified. Hispanics had a 49% increase in odds of being admitted to the ICU secondary to vasculitis when compared to Caucasians [OR 1.49 (95% CI 0.72, 3.07)]. Hispanics were noted to have more flares with a maximum recorded number of flares for a single patient to be 15 compared to 7 for a Caucasian patient. They also had a 71% increase in odds of having kidney disease in comparison to Caucasians [OR 1.71 (95% CI 0.85, 3.43)]. Of the patients with kidney disease, Hispanics had a 95% increase in odds of having ESRD when compared to Caucasians [OR 1.95 (95% CI 0.68, 5.55)]. See table 2. The BVAS and VDI averages between Hispanics and Caucasians were comparable at 8.53 ± 7.3 vs 7.69 ± 6.3 and 2.32 ± 2.0 vs 2.2 ± 1.5, respectively (p = 0.49; p = 0.70).  See table 3. Although we observed differences in disease severity proportions between Hispanics and Caucasians, the measures of association were not statistically significant.

Conclusion: Like the Chicago study, we saw greater incidences of renal disease and increased severity in Hispanics compared to Caucasians, as defined by increased rates of ICU admissions and vasculitis flares, despite analogous average BVAS and VDI scores. Our data shows that conventionally used disease activity scores may not convey the seriousness of renal or pulmonary vasculitis in Hispanic populations. Clinicians treating Hispanic patients with AAV should have a high index of suspicion for more severe disease in this patient population when compared to Caucasians.

Table 1. Observed Attributes of Hispanic and Caucasian patients with ANCA-associated Vasculitis.

Table 2. Odds Ratio for Ethnicity

Table 3. Independent Sample T-test of BVAS and VDI.


Disclosure: S. Lee, None; P. Injean, None; P. Tran, None; D. Panikkath, None; C. Downey, None.

To cite this abstract in AMA style:

Lee S, Injean P, Tran P, Panikkath D, Downey C. ANCA-associated Vasculitis in Caucasian and Hispanics of the Inland Empire of Southern California [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/anca-associated-vasculitis-in-caucasian-and-hispanics-of-the-inland-empire-of-southern-california/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/anca-associated-vasculitis-in-caucasian-and-hispanics-of-the-inland-empire-of-southern-california/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology